Skip to main content

Table 3 Prevalence of antimicrobial resistance in healthcare-onset/associated E. coli bacteriuria episodes compared to those that are community-onset, 2014–2020

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

 

RR (95% CI)

NIT

T/S

CIP

ESBL

Any AMR

MDR

Community onset (reference)

      

Healthcare onset/associated

1.98 (1.40, 2.79)

1.23 (1.14, 1.32)

1.96 (1.80, 2.13)

3.00 (2.65, 3.39)

1.17 (1.13, 1.22)

1.86 (1.69, 2.05)

  1. Data from a public healthcare system including inpatient and outpatient services and a skilled nursing facility; RR: risk ratio, NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance